Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China

• Published in: BMC cancer Vol. 21; no. 1; pp. 1 - 9
• Main Authors: Guo, Xu, Ma, Wenjuan, Wu, Haixiao, Xu, Yao, Wang, Dezheng, Zhang, Shuang, Liu, Zheng, Chekhonin, Vladimir P., Peltzer, Karl, Zhang, Jin, Wang, Xin, Zhang, Chao
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 26.05.2021; BioMed Central; BMC
• Subjects: Adenocarcinoma; Alkaline phosphatase; Antigens; Bone cancer; Bone surgery; Bone tumors; Cancer therapies; Carcinoembryonic antigen; Care and treatment; Chemotherapy; Complications and side effects; Cytokeratin; Development and progression; Drugs; Evaluation; L-Lactate dehydrogenase; Lactic acid; Lung Cancer; Lymph nodes; Lymphatic system; Medical prognosis; Metastases; Metastasis; Patients; Phosphopyruvate hydratase; Prognosis; Smoking; Squamous cell carcinoma; Synchronous bone metastasis; China; Tianjin China

Background This study aimed to describe the incidence, clinical characteristics, and prognosis of lung cancer patients with synchronous bone metastasis (SBM) and to analyze the prognostic factors of the lung cancer patients with SBM. Methods A total of 15,716 lung cancer patients who were diagnosed...